- Home
- ENSC vs PRSO Comparison
ENSC vs PRSO Comparison
Compare ENSC & PRSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENSC
- PRSO
- Stock Information
- Founded
- ENSC 2003
- PRSO 2008
- Country
- ENSC United States
- PRSO United States
- Employees
- ENSC N/A
- PRSO N/A
- Industry
- ENSC Biotechnology: Pharmaceutical Preparations
- PRSO Semiconductors
- Sector
- ENSC Health Care
- PRSO Technology
- Exchange
- ENSC Nasdaq
- PRSO Nasdaq
- Market Cap
- ENSC 6.4M
- PRSO 5.4M
- IPO Year
- ENSC N/A
- PRSO 2001
- Fundamental
- Price
- ENSC $2.10
- PRSO $1.15
- Analyst Decision
- ENSC
- PRSO Strong Buy
- Analyst Count
- ENSC 0
- PRSO 1
- Target Price
- ENSC N/A
- PRSO $3.00
- AVG Volume (30 Days)
- ENSC 54.6K
- PRSO 10.3M
- Earning Date
- ENSC 11-11-2025
- PRSO 11-11-2025
- Dividend Yield
- ENSC N/A
- PRSO N/A
- EPS Growth
- ENSC N/A
- PRSO N/A
- EPS
- ENSC N/A
- PRSO N/A
- Revenue
- ENSC $7,413,722.00
- PRSO $13,608,000.00
- Revenue This Year
- ENSC N/A
- PRSO N/A
- Revenue Next Year
- ENSC $1,354.55
- PRSO $47.61
- P/E Ratio
- ENSC N/A
- PRSO N/A
- Revenue Growth
- ENSC 415.58
- PRSO 1.80
- 52 Week Low
- ENSC $1.62
- PRSO $0.52
- 52 Week High
- ENSC $14.67
- PRSO $2.34
- Technical
- Relative Strength Index (RSI)
- ENSC 48.61
- PRSO 55.25
- Support Level
- ENSC $2.02
- PRSO $1.18
- Resistance Level
- ENSC $2.19
- PRSO $1.35
- Average True Range (ATR)
- ENSC 0.10
- PRSO 0.15
- MACD
- ENSC 0.00
- PRSO 0.02
- Stochastic Oscillator
- ENSC 41.45
- PRSO 40.74
About ENSC Ensysce Biosciences Inc.
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.
About PRSO Peraso Inc.
Peraso Inc is a fabless semiconductor company focused on the development and sale of: i) millimeter wavelength wireless technology, or mmWave, semiconductor devices and antenna modules based on its proprietary semiconductor devices and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual property, or IP. The company's primary focus is the development of mmWave, which is generally described as the frequency band from 24 Gigahertz, or GHz, to 300 GHz. Geographically the company generates revenue from the United States, Hong Kong, Taiwan, and the Rest of the World.